{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:48:07Z","timestamp":1787068087395,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1245\/s10434-022-11577-2","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T16:02:42Z","timestamp":1647964962000},"page":"5243-5251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study"],"prefix":"10.1245","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-6474","authenticated-orcid":false,"given":"Abdelkader","family":"Taibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Sgarbura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia M.","family":"Bardet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alyami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoual","family":"Bakrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvaine","family":"Durand Fontanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Eveno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Gagniere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Pache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pocard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Quenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Teixeira Farinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Thibaudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"issue":"2","key":"11577_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5005\/jp-journals-10018-1241","volume":"7","author":"AI Valderrama-Trevi\u00f1o","year":"2017","unstructured":"Valderrama-Trevi\u00f1o AI, Barrera-Mera B, Ceballos-Villalva JC, Montalvo-Jav\u00e9 EE. Hepatic metastasis from colorectal cancer. Euroasian J Hepato-Gastroenterol. 2017;7(2):166\u201375.","journal-title":"Euroasian J Hepato-Gastroenterol"},{"key":"11577_CR2","doi-asserted-by":"publisher","first-page":"29765","DOI":"10.1038\/srep29765","volume":"6","author":"M Riihim\u00e4ki","year":"2016","unstructured":"Riihim\u00e4ki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765.","journal-title":"Sci Rep"},{"issue":"5","key":"11577_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jviscsurg.2019.08.002","volume":"156","author":"K Abboud","year":"2019","unstructured":"Abboud K, Andr\u00e9 T, Brunel M, Ducreux M, Eveno C, Glehen O, et al. Management of colorectal peritoneal metastases: expert opinion. J Visc Surg. 2019;156(5):377\u20139.","journal-title":"J Visc Surg"},{"issue":"12","key":"11577_CR4","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.ejso.2018.07.003","volume":"44","author":"M Bushati","year":"2018","unstructured":"Bushati M, Rovers KP, Sommariva A, Sugarbaker PH, Morris DL, Yonemura Y, et al. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol. 2018;44(12):1942\u20138.","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"11577_CR5","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1002\/cncr.32874","volume":"126","author":"Chicago Consensus Working Group","year":"2020","unstructured":"Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: management of colorectal metastases. Cancer. 2020;126(11):2534\u201340.","journal-title":"Cancer"},{"issue":"2","key":"11577_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1515\/pp-2017-0010","volume":"2","author":"E de Bree","year":"2017","unstructured":"de Bree E, Michelakis D, Stamatiou D, Romanos J, Zoras O. Pharmacological principles of intraperitoneal and bidirectional chemotherapy. Pleura Peritoneum. 2017;2(2):47\u201362.","journal-title":"Pleura Peritoneum"},{"issue":"2","key":"11577_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","volume":"21","author":"W Solass","year":"2014","unstructured":"Solass W, Kerb R, M\u00fcrdter T, Giger-Pabst U, Strumberg D, Tempfer C, et al. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol. 2014;21(2):553\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"11577_CR8","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","volume":"20","author":"M Alyami","year":"2019","unstructured":"Alyami M, H\u00fcbner M, Grass F, Bakrin N, Villeneuve L, Laplace N, et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 2019;20(7):e368\u201377.","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"11577_CR9","doi-asserted-by":"publisher","first-page":"S242","DOI":"10.21037\/jgo-20-257","volume":"12","author":"RJ Lurvink","year":"2021","unstructured":"Lurvink RJ, Rovers KP, Nienhuijs SW, Creemers G-J, Burger JWA, de Hingh IHJ. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic review. J Gastrointest Oncol. 2021;12(Suppl 1):S242\u201358.","journal-title":"J Gastrointest Oncol"},{"issue":"12","key":"11577_CR10","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.ejso.2019.05.007","volume":"45","author":"O Sgarbura","year":"2019","unstructured":"Sgarbura O, H\u00fcbner M, Alyami M, Eveno C, Gagni\u00e8re J, Pache B, et al. Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: a multicenter study. Eur J Surg Oncol. 2019;45(12):2386\u201391.","journal-title":"Eur J Surg Oncol"},{"key":"11577_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejca.2020.09.010","volume":"140","author":"F Dumont","year":"2020","unstructured":"Dumont F, Passot C, Raoul J-L, Kepenekian V, Leli\u00e8vre B, Boisdron-Celle M, et al. A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers. Eur J Cancer. 2020;140:37\u201344.","journal-title":"Eur J Cancer"},{"issue":"9","key":"11577_CR12","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1245\/s10434-020-09508-0","volume":"28","author":"N Tabchouri","year":"2021","unstructured":"Tabchouri N, Buggisch J, Demtr\u00f6der CR, Thiery J, Rezniczek G, Tempfer CB, et al. Pressurized intraperitoneal aerosol chemotherapy for colorectal peritoneal metastases. Ann Surg Oncol. 2021;28(9):5275\u201386.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"11577_CR13","doi-asserted-by":"publisher","first-page":"20200109","DOI":"10.1515\/pp-2020-0109","volume":"5","author":"SB Elleb\u00e6k","year":"2020","unstructured":"Elleb\u00e6k SB, Graversen M, Detlefsen S, Lundell L, Fristrup CW, Pfeiffer P, et al. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients. Pleura Peritoneum. 2020;5(2):20200109.","journal-title":"Pleura Peritoneum"},{"issue":"7","key":"11577_CR14","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1158\/1078-0432.CCR-20-2152","volume":"27","author":"G Kim","year":"2021","unstructured":"Kim G, Tan HL, Sundar R, Lieske B, Chee CE, Ho J, et al. PIPAC-OX: a phase I study of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy in patients with peritoneal metastases. Clin Cancer Res. 2021;27(7):1875\u201381.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"11577_CR15","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1245\/s10434-020-09558-4","volume":"28","author":"KP Rovers","year":"2021","unstructured":"Rovers KP, Wassenaar ECE, Lurvink RJ, Creemers G-JM, Burger JWA, Los M, et al. Pressurized intraperitoneal aerosol chemotherapy (oxaliplatin) for unresectable colorectal peritoneal metastases: a multicenter, single-arm, phase II trial (CRC-PIPAC). Ann Surg Oncol. 2021;28(9):5311\u201326.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"11577_CR16","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ejso.2017.03.019","volume":"43","author":"M H\u00fcbner","year":"2017","unstructured":"H\u00fcbner M, Grass F, Teixeira-Farinha H, Pache B, Mathevet P, Demartines N. Pressurized intraperitoneal aerosol chemotherapy\u2014practical aspects. Eur J Surg Oncol. 2017;43(6):1102\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"11577_CR17","volume-title":"Common terminology criteria for adverse events (CTCAE), version 4.0","author":"National Cancer Institute","year":"2009","unstructured":"National Cancer Institute. Common terminology criteria for adverse events (CTCAE), version 4.0. Bethesda: National Cancer Institute; 2009."},{"issue":"2","key":"11577_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/pp-2016-0011","volume":"1","author":"W Solass","year":"2016","unstructured":"Solass W, Sempoux C, Detlefsen S, Carr NJ, Bibeau F. Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS). Pleura Peritoneum. 2016;1(2):99\u2013107.","journal-title":"Pleura Peritoneum"},{"issue":"1","key":"11577_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejso.2020.08.020","volume":"47","author":"O Sgarbura","year":"2021","unstructured":"Sgarbura O, Villeneuve L, Alyami M, Bakrin N, Torrent JJ, Eveno C, et al. Current practice of pressurized intraperitoneal aerosol chemotherapy (PIPAC): Still standardized or on the verge of diversification? Eur J Surg Oncol. 2021;47(1):149\u201356.","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"11577_CR20","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1245\/s10434-020-09332-6","volume":"28","author":"A Taibi","year":"2021","unstructured":"Taibi A, Teixeira Farinha H, Durand Fontanier S, Sayedalamin Z, H\u00fcbner M, Sgarbura O. Pressurized intraperitoneal aerosol chemotherapy enhanced by electrostatic precipitation (ePIPAC) for patients with peritoneal metastases. Ann Surg Oncol. 2021;28(7):3852\u201360.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"11577_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/codi.13130","volume":"18","author":"C Demtr\u00f6der","year":"2016","unstructured":"Demtr\u00f6der C, Solass W, Zieren J, Strumberg D, Giger-Pabst U, Reymond M-A. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis. Colorectal Dis. 2016;18(4):364\u201371.","journal-title":"Colorectal Dis"},{"issue":"3","key":"11577_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10585-018-9895-9","volume":"35","author":"M Graversen","year":"2018","unstructured":"Graversen M, Detlefsen S, Pfeiffer P, Lundell L, Mortensen MB. Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey. Clin Exp Metastasis. 2018;35(3):103\u20138.","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"11577_CR23","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1111\/all.14679","volume":"76","author":"A Gauthier","year":"2021","unstructured":"Gauthier A, Mankouri F, Demoly P, Sgarbura O, Mirela Chiriac A. Hypersensitivity reactions to platinum-based compounds in the context of pressurized intraperitoneal aerosol chemotherapy (PIPAC): description and management. Allergy. 2021;76(6):1882\u20135.","journal-title":"Allergy"},{"issue":"2","key":"11577_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jviscsurg.2019.01.006","volume":"156","author":"G Mariano","year":"2019","unstructured":"Mariano G, Pocard M, Eveno C. PIPAC: 8 key points for a good practice with video. J Visc Surg. 2019;156(2):169\u201371.","journal-title":"J Visc Surg"},{"issue":"2","key":"11577_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s11605-017-3565-0","volume":"22","author":"J-B Cazauran","year":"2018","unstructured":"Cazauran J-B, Alyami M, Lasseur A, Gybels I, Glehen O, Bakrin N. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedure for non-resectable peritoneal carcinomatosis (with video). J Gastrointest Surg. 2018;22(2):374\u20135.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"11577_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/DCR.0000000000001565","volume":"63","author":"CS Winkler","year":"2020","unstructured":"Winkler CS, Sandhu J, Pettke E, Merchea A, Fong Y, Kumara HMCS, et al. Pressurized intraperitoneal aerosol chemotherapy, a palliative treatment approach for patients with peritoneal carcinomatosis: description of method and systematic review of literature. Dis Colon Rectum. 2020;63(2):242\u201355.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"11577_CR27","doi-asserted-by":"publisher","first-page":"20190004","DOI":"10.1515\/pp-2019-0004","volume":"4","author":"T Glatz","year":"2019","unstructured":"Glatz T, Horvath P, Lang SA, Archid R, Nadiradze G. Staging laparoscopy and pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis: safe access to the abdomen. Pleura Peritoneum. 2019;4(1):20190004.","journal-title":"Pleura Peritoneum"},{"issue":"1","key":"11577_CR28","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1200\/JCO.2000.18.1.136","volume":"18","author":"S Giacchetti","year":"2000","unstructured":"Giacchetti S, Perpoint B, Zidani R, Le Bail N, Faggiuolo R, Focan C, et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol. 2000;18(1):136\u201347.","journal-title":"J Clin Oncol"},{"issue":"12 Suppl 11","key":"11577_CR29","first-page":"9","volume":"14","author":"ML Rothenberg","year":"2000","unstructured":"Rothenberg ML. Efficacy of oxaliplatin in the treatment of colorectal cancer. Oncol (Williston Park). 2000;14(12 Suppl 11):9\u201314.","journal-title":"Oncol (Williston Park)"},{"issue":"11","key":"11577_CR30","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.bcp.2009.07.006","volume":"78","author":"D Theile","year":"2009","unstructured":"Theile D, Grebhardt S, Haefeli WE, Weiss J. Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy. Biochem Pharmacol. 2009;78(11):1366\u201373.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"11577_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.suronc.2018.05.004","volume":"27","author":"D Badrudin","year":"2018","unstructured":"Badrudin D, Sideris L, Leblond FA, Pichette V, Cloutier AS, Drolet P, et al. Rationale for the administration of systemic 5-FU in combination with heated intraperitonal oxaliplatin. Surg Oncol. 2018;27(2):275\u20139.","journal-title":"Surg Oncol"},{"issue":"2","key":"11577_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, Go\u00e9r\u00e9 D, Ghouti L, Pocard M, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):25\u2013266.","journal-title":"Lancet Oncol"},{"issue":"5","key":"11577_CR33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe J-M, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27(5):681\u20135.","journal-title":"J Clin Oncol"},{"issue":"1","key":"11577_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejso.2019.06.028","volume":"47","author":"M Alyami","year":"2021","unstructured":"Alyami M, Mercier F, Siebert M, Bonnot P-E, Laplace N, Villeneuve L, et al. Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2021;47(1):128\u201333.","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"11577_CR35","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/his.13829","volume":"74","author":"W Solass","year":"2019","unstructured":"Solass W, Sempoux C, Carr NJ, Bibeau F, Neureiter D, J\u00e4ger T, et al. Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis. Histopathology. 2019;74(7):1014\u201324.","journal-title":"Histopathology"},{"issue":"6","key":"11577_CR36","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.21037\/jgo.2017.08.13","volume":"8","author":"P Achilli","year":"2017","unstructured":"Achilli P, De Martini P, Ceresoli M, Mari GM, Costanzi A, Maggioni D, et al. Tumor response evaluation after neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: a prospective, multi-center cohort study. J Gastrointest Oncol. 2017;8(6):1018\u201325.","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"11577_CR37","first-page":"513","volume":"14","author":"P Bertheau","year":"2005","unstructured":"Bertheau P, Lerebours F, Mounier N, de Roquancourt A, Espi\u00e9 M, Clot P, et al. Prognostic significance of a combined clinicopathologic score for response to primary systemic therapy in locally advanced breast cancer. Oncol Rep. 2005;14(2):513\u201320.","journal-title":"Oncol Rep"},{"issue":"4","key":"11577_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.suronc.2012.07.003","volume":"21","author":"T Gruenberger","year":"2012","unstructured":"Gruenberger T, Arnold D, Rubbia-Brandt L. Pathologic response to bevacizumab-containing chemotherapy in patients with colorectal liver metastases and its correlation with survival. Surg Oncol. 2012;21(4):309\u201315.","journal-title":"Surg Oncol"},{"issue":"2","key":"11577_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/annonc\/mdl386","volume":"18","author":"L Rubbia-Brandt","year":"2007","unstructured":"Rubbia-Brandt L, Giostra E, Brezault C, Roth AD, Andres A, Audard V, et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol. 2007;18(2):299\u2013304.","journal-title":"Ann Oncol"},{"issue":"33","key":"11577_CR40","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","volume":"26","author":"DG Blazer","year":"2008","unstructured":"Blazer DG, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008;26(33):5344\u201351.","journal-title":"J Clin Oncol"},{"issue":"8","key":"11577_CR41","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1245\/s10434-014-3647-0","volume":"21","author":"G Passot","year":"2014","unstructured":"Passot G, You B, Boschetti G, Fontaine J, Isaac S, Decullier E, et al. Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis. Ann Surg Oncol. 2014;21(8):2608\u201314.","journal-title":"Ann Surg Oncol"},{"key":"11577_CR42","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.suronc.2020.02.014","volume":"33","author":"A Taibi","year":"2020","unstructured":"Taibi A, Lo Dico R, Kaci R, Naneix AL, Mathonnet M, Pocard M. Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG. Surg Oncol. 2020;33:158\u201363.","journal-title":"Surg Oncol"},{"issue":"4","key":"11577_CR43","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/his.14092","volume":"77","author":"N Benzerdjeb","year":"2020","unstructured":"Benzerdjeb N, Durieux E, Tantot J, Isaac S, Fontaine J, Harou O, et al. Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis. Histopathology. 2020;77(4):548\u201359.","journal-title":"Histopathology"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11577-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-11577-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11577-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T19:13:43Z","timestamp":1656616423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-11577-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["11577"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-11577-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"assertion":[{"value":"7 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Olivier Glehen is consultant for Gamida. Abdelkader Taibi, Olivia Sgarbura, Martin H\u00fcbner, Sylvia M. Bardet, Mohammed Alyami, Naoual Bakrin, Sylvaine Durand Fontanier, Clarisse Eveno, Johan Gagniere, Basile Pache, Marc Pocard, Fran\u00e7ois Quenet, Hugo Teixeira Farinha, Emilie Thibaudeau, and Frederic Dumont have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}